UK markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0210+0.0010 (+0.05%)
As of 11:40AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-11,459
-14,578
-12,093
-12,748
-4,600
Stock-based compensation
3,250
3,207
2,872
5,155
695.833
Change in working capital
662.418
1,011
1,248
141.283
-801.166
Other working capital
-7,547
-9,801
-7,542
-5,014
-3,352
Other non-cash items
559.583
559.583
430.68
1,588
572.113
Net cash provided by operating activities
-7,547
-9,801
-7,542
-5,014
-3,352
Cash flows from financing activities
Common stock issued
0
5,944
3,695
14,797
3,977
Net cash used provided by (used for) financing activities
3,695
8,163
3,695
14,797
4,044
Net change in cash
-3,852
-1,638
-3,847
9,783
692.089
Cash at beginning of period
14,459
9,112
12,959
3,175
2,483
Cash at end of period
10,607
7,474
9,112
12,959
3,175
Free cash flow
Operating cash flow
-7,547
-9,801
-7,542
-5,014
-3,352
Free cash flow
-7,547
-9,801
-7,542
-5,014
-3,352